Global Lapatinib Market Growth (Status and Outlook) 2023-2029

March 2023 | 61 pages | ID: G506F5AEE8BEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Lapatinib (INN), used in the form of lapatinib ditosylate (USAN) (trade names Tykerb and Tyverb) is an orally active drug for breast cancer and other solid tumours.

LPI (LP Information)' newest research report, the “Lapatinib Industry Forecast” looks at past sales and reviews total world Lapatinib sales in 2022, providing a comprehensive analysis by region and market sector of projected Lapatinib sales for 2023 through 2029. With Lapatinib sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lapatinib industry.

This Insight Report provides a comprehensive analysis of the global Lapatinib landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Lapatinib portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Lapatinib market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lapatinib and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lapatinib.

The global Lapatinib market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Lapatinib is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Lapatinib is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Lapatinib is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Lapatinib players cover Novartis. etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Lapatinib market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type

• 250 mg Tablets
• Type II

Segmentation by application

• Hospital
• Drug store

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Novartis

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Lapatinib Market Size 2018-2029
  2.1.2 Lapatinib Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Lapatinib Segment by Type
  2.2.1 250 mg Tablets
  2.2.2 Type II
2.3 Lapatinib Market Size by Type
  2.3.1 Lapatinib Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global Lapatinib Market Size Market Share by Type (2018-2023)
2.4 Lapatinib Segment by Application
  2.4.1 Hospital
  2.4.2 Drug store
2.5 Lapatinib Market Size by Application
  2.5.1 Lapatinib Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global Lapatinib Market Size Market Share by Application (2018-2023)

3 LAPATINIB MARKET SIZE BY PLAYER

3.1 Lapatinib Market Size Market Share by Players
  3.1.1 Global Lapatinib Revenue by Players (2018-2023)
  3.1.2 Global Lapatinib Revenue Market Share by Players (2018-2023)
3.2 Global Lapatinib Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 LAPATINIB BY REGIONS

4.1 Lapatinib Market Size by Regions (2018-2023)
4.2 Americas Lapatinib Market Size Growth (2018-2023)
4.3 APAC Lapatinib Market Size Growth (2018-2023)
4.4 Europe Lapatinib Market Size Growth (2018-2023)
4.5 Middle East & Africa Lapatinib Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas Lapatinib Market Size by Country (2018-2023)
5.2 Americas Lapatinib Market Size by Type (2018-2023)
5.3 Americas Lapatinib Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Lapatinib Market Size by Region (2018-2023)
6.2 APAC Lapatinib Market Size by Type (2018-2023)
6.3 APAC Lapatinib Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Lapatinib by Country (2018-2023)
7.2 Europe Lapatinib Market Size by Type (2018-2023)
7.3 Europe Lapatinib Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Lapatinib by Region (2018-2023)
8.2 Middle East & Africa Lapatinib Market Size by Type (2018-2023)
8.3 Middle East & Africa Lapatinib Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL LAPATINIB MARKET FORECAST

10.1 Global Lapatinib Forecast by Regions (2024-2029)
  10.1.1 Global Lapatinib Forecast by Regions (2024-2029)
  10.1.2 Americas Lapatinib Forecast
  10.1.3 APAC Lapatinib Forecast
  10.1.4 Europe Lapatinib Forecast
  10.1.5 Middle East & Africa Lapatinib Forecast
10.2 Americas Lapatinib Forecast by Country (2024-2029)
  10.2.1 United States Lapatinib Market Forecast
  10.2.2 Canada Lapatinib Market Forecast
  10.2.3 Mexico Lapatinib Market Forecast
  10.2.4 Brazil Lapatinib Market Forecast
10.3 APAC Lapatinib Forecast by Region (2024-2029)
  10.3.1 China Lapatinib Market Forecast
  10.3.2 Japan Lapatinib Market Forecast
  10.3.3 Korea Lapatinib Market Forecast
  10.3.4 Southeast Asia Lapatinib Market Forecast
  10.3.5 India Lapatinib Market Forecast
  10.3.6 Australia Lapatinib Market Forecast
10.4 Europe Lapatinib Forecast by Country (2024-2029)
  10.4.1 Germany Lapatinib Market Forecast
  10.4.2 France Lapatinib Market Forecast
  10.4.3 UK Lapatinib Market Forecast
  10.4.4 Italy Lapatinib Market Forecast
  10.4.5 Russia Lapatinib Market Forecast
10.5 Middle East & Africa Lapatinib Forecast by Region (2024-2029)
  10.5.1 Egypt Lapatinib Market Forecast
  10.5.2 South Africa Lapatinib Market Forecast
  10.5.3 Israel Lapatinib Market Forecast
  10.5.4 Turkey Lapatinib Market Forecast
  10.5.5 GCC Countries Lapatinib Market Forecast
10.6 Global Lapatinib Forecast by Type (2024-2029)
10.7 Global Lapatinib Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 Novartis
  11.1.1 Novartis Company Information
  11.1.2 Novartis Lapatinib Product Offered
  11.1.3 Novartis Lapatinib Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 Novartis Main Business Overview
  11.1.5 Novartis Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Lapatinib Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of 250 mg Tablets
Table 3. Major Players of Type II
Table 4. Lapatinib Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Lapatinib Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Lapatinib Market Size Market Share by Type (2018-2023)
Table 7. Lapatinib Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Lapatinib Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Lapatinib Market Size Market Share by Application (2018-2023)
Table 10. Global Lapatinib Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Lapatinib Revenue Market Share by Player (2018-2023)
Table 12. Lapatinib Key Players Head office and Products Offered
Table 13. Lapatinib Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Lapatinib Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Lapatinib Market Size Market Share by Regions (2018-2023)
Table 18. Global Lapatinib Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Lapatinib Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Lapatinib Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Lapatinib Market Size Market Share by Country (2018-2023)
Table 22. Americas Lapatinib Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Lapatinib Market Size Market Share by Type (2018-2023)
Table 24. Americas Lapatinib Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Lapatinib Market Size Market Share by Application (2018-2023)
Table 26. APAC Lapatinib Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Lapatinib Market Size Market Share by Region (2018-2023)
Table 28. APAC Lapatinib Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Lapatinib Market Size Market Share by Type (2018-2023)
Table 30. APAC Lapatinib Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Lapatinib Market Size Market Share by Application (2018-2023)
Table 32. Europe Lapatinib Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Lapatinib Market Size Market Share by Country (2018-2023)
Table 34. Europe Lapatinib Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Lapatinib Market Size Market Share by Type (2018-2023)
Table 36. Europe Lapatinib Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Lapatinib Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Lapatinib Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Lapatinib Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Lapatinib Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Lapatinib Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Lapatinib Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Lapatinib Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Lapatinib
Table 45. Key Market Challenges & Risks of Lapatinib
Table 46. Key Industry Trends of Lapatinib
Table 47. Global Lapatinib Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Lapatinib Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Lapatinib Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Lapatinib Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Novartis Details, Company Type, Lapatinib Area Served and Its Competitors
Table 52. Novartis Lapatinib Product Offered
Table 53. Novartis Lapatinib Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Novartis Main Business
Table 55. Novartis Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Lapatinib Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Lapatinib Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Lapatinib Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Lapatinib Sales Market Share by Country/Region (2022)
Figure 8. Lapatinib Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Lapatinib Market Size Market Share by Type in 2022
Figure 10. Lapatinib in Hospital
Figure 11. Global Lapatinib Market: Hospital (2018-2023) & ($ Millions)
Figure 12. Lapatinib in Drug store
Figure 13. Global Lapatinib Market: Drug store (2018-2023) & ($ Millions)
Figure 14. Global Lapatinib Market Size Market Share by Application in 2022
Figure 15. Global Lapatinib Revenue Market Share by Player in 2022
Figure 16. Global Lapatinib Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Lapatinib Market Size 2018-2023 ($ Millions)
Figure 18. APAC Lapatinib Market Size 2018-2023 ($ Millions)
Figure 19. Europe Lapatinib Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Lapatinib Market Size 2018-2023 ($ Millions)
Figure 21. Americas Lapatinib Value Market Share by Country in 2022
Figure 22. United States Lapatinib Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Lapatinib Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Lapatinib Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Lapatinib Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Lapatinib Market Size Market Share by Region in 2022
Figure 27. APAC Lapatinib Market Size Market Share by Type in 2022
Figure 28. APAC Lapatinib Market Size Market Share by Application in 2022
Figure 29. China Lapatinib Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Lapatinib Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Lapatinib Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Lapatinib Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Lapatinib Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Lapatinib Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Lapatinib Market Size Market Share by Country in 2022
Figure 36. Europe Lapatinib Market Size Market Share by Type (2018-2023)
Figure 37. Europe Lapatinib Market Size Market Share by Application (2018-2023)
Figure 38. Germany Lapatinib Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Lapatinib Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Lapatinib Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Lapatinib Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Lapatinib Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Lapatinib Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Lapatinib Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Lapatinib Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Lapatinib Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Lapatinib Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Lapatinib Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Lapatinib Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Lapatinib Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Lapatinib Market Size 2024-2029 ($ Millions)
Figure 52. APAC Lapatinib Market Size 2024-2029 ($ Millions)
Figure 53. Europe Lapatinib Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Lapatinib Market Size 2024-2029 ($ Millions)
Figure 55. United States Lapatinib Market Size 2024-2029 ($ Millions)
Figure 56. Canada Lapatinib Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Lapatinib Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Lapatinib Market Size 2024-2029 ($ Millions)
Figure 59. China Lapatinib Market Size 2024-2029 ($ Millions)
Figure 60. Japan Lapatinib Market Size 2024-2029 ($ Millions)
Figure 61. Korea Lapatinib Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Lapatinib Market Size 2024-2029 ($ Millions)
Figure 63. India Lapatinib Market Size 2024-2029 ($ Millions)
Figure 64. Australia Lapatinib Market Size 2024-2029 ($ Millions)
Figure 65. Germany Lapatinib Market Size 2024-2029 ($ Millions)
Figure 66. France Lapatinib Market Size 2024-2029 ($ Millions)
Figure 67. UK Lapatinib Market Size 2024-2029 ($ Millions)
Figure 68. Italy Lapatinib Market Size 2024-2029 ($ Millions)
Figure 69. Russia Lapatinib Market Size 2024-2029 ($ Millions)
Figure 70. Spain Lapatinib Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Lapatinib Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Lapatinib Market Size 2024-2029 ($ Millions)
Figure 73. Israel Lapatinib Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Lapatinib Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Lapatinib Market Size 2024-2029 ($ Millions)
Figure 76. Global Lapatinib Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Lapatinib Market Size Market Share Forecast by Application (2024-2029)